Your browser doesn't support javascript.
loading
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas.
Kocakavuk, Emre; Johnson, Kevin C; Sabedot, Thais S; Reinhardt, Hans Christian; Noushmehr, Houtan; Verhaak, Roel G W.
Affiliation
  • Kocakavuk E; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA.
  • Johnson KC; Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), National Center for Tumor Diseases (NCT) West, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Sabedot TS; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA.
  • Reinhardt HC; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, Michigan, USA.
  • Noushmehr H; Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), National Center for Tumor Diseases (NCT) West, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Verhaak RGW; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, Michigan, USA.
Neuro Oncol ; 25(9): 1721-1723, 2023 09 05.
Article in En | MEDLINE | ID: mdl-37329568
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Astrocytoma / Brain Neoplasms / Glioma Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Astrocytoma / Brain Neoplasms / Glioma Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2023 Type: Article Affiliation country: United States